NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Excelsior Biopharma Inc (TWO: 6496)

 
6496 Technical Analysis
4
As on 14th Jan 2025 6496 STOCK Price closed @ 32.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 28.97 & Strong Buy for SHORT-TERM with Stoploss of 29.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

6496STOCK Price

Open 32.65 Change Price %
High 32.65 1 Day -1.15 -3.47
Low 32.00 1 Week 0.00 0.00
Close 32.00 1 Month 2.05 6.84
Volume 21244 1 Year 1.60 5.26
52 Week High 36.50 | 52 Week Low 27.60
 
TWO Taiwan Most Active Stocks
1815 28.75 5.31%
3264 64.70 4.86%
6547 50.40 2.23%
4979 190.00 -2.06%
4931 70.00 0.00%
3379 43.85 9.90%
3163 153.50 0.66%
4991 121.50 -1.62%
3078 76.00 -2.06%
3551 145.00 9.85%
 
TWO Taiwan Top Gainers Stocks
3438 60.80 9.95%
3379 43.85 9.90%
3379 43.85 9.90%
6683 511.00 9.89%
6485 42.25 9.88%
3551 145.00 9.85%
4130 22.95 9.81%
4130 22.95 9.81%
5543 21.55 8.56%
8937 165.00 8.20%
 
TWO Taiwan Top Losers Stocks
3373 27.80 -9.74%
1569 50.00 -7.06%
1569 50.00 -7.06%
6144 30.60 -5.70%
8080 32.00 -4.48%
8080 32.00 -4.48%
8080 32.00 -4.48%
4109 23.00 -4.37%
3131 1320.00 -4.35%
6496 32.00 -3.47%
 
 
6496
Daily Charts
6496
Intraday Charts
Whats New @
Bazaartrend
6496
Free Analysis
 
6496 Important Levels Intraday
RESISTANCE33.25
RESISTANCE32.85
RESISTANCE32.60
RESISTANCE32.35
SUPPORT31.65
SUPPORT31.40
SUPPORT31.15
SUPPORT30.75
 
6496 Forecast January 2025
4th UP Forecast36.91
3rd UP Forecast35.34
2nd UP Forecast34.36
1st UP Forecast33.39
1st DOWN Forecast30.61
2nd DOWN Forecast29.64
3rd DOWN Forecast28.66
4th DOWN Forecast27.09
 
6496 Weekly Forecast
4th UP Forecast34.22
3rd UP Forecast33.51
2nd UP Forecast33.07
1st UP Forecast32.63
1st DOWN Forecast31.37
2nd DOWN Forecast30.93
3rd DOWN Forecast30.49
4th DOWN Forecast29.78
 
6496 Forecast2025
4th UP Forecast57.92
3rd UP Forecast49.61
2nd UP Forecast44.47
1st UP Forecast39.33
1st DOWN Forecast24.67
2nd DOWN Forecast19.53
3rd DOWN Forecast14.39
4th DOWN Forecast6.08
 
 
6496 Other Details
Segment EQ
Market Capital 1353342976.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
6496 Address
6496
 
6496 Latest News
 
Your Comments and Response on Excelsior Biopharma Inc
 
6496 Business Profile
Excelsior Biopharma Inc. develops pharmaceutical products in Taiwan. The company offers prescription drugs, over-the-counter drugs, medical devices, healthcare food products, medical supplies, and skin products. It provides its products for the therapeutic areas, such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics and gynecology, anesthesiology, orthopedics, neonatology, oncology, pulmonary medicine, nephology, and others, etc. The company also offers test kits under the Actim name to detect inflected C-reactive protein, influenza virus, colorectal cancer, acute pancreatitis, preterm birth, and early water-breaking. In addition, it provides oral care products, including oral cleansing toothpaste, mouthwash and gel; and health food and cosmetic products. Excelsior Biopharma Inc. also exports its products. The company was formerly known as Excelsior Enterprise Co., Ltd. Excelsior Biopharma Inc. was founded in 1988 and is headquartered in Taipei City, Taiwan. Address: No.3, Park Street, Taipei, Taiwan
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service